Business Description
Lir Life Sciences Corp
NAICS : 541710
SIC : 3741
ISIN : CA50206C1005
Description
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 26.31 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.64 | |||||
9-Day RSI | 65.95 | |||||
14-Day RSI | 56 | |||||
3-1 Month Momentum % | -18.12 | |||||
6-1 Month Momentum % | -83.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.35 | |||||
Quick Ratio | 13.35 | |||||
Cash Ratio | 11.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 1.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -473.99 | |||||
ROA % | -353.31 | |||||
ROIC % | -2311.71 | |||||
ROC (Joel Greenblatt) % | -13564.71 | |||||
ROCE % | -422.34 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 10.53 | |||||
Price-to-Tangible-Book | 8.93 | |||||
EV-to-EBIT | -4.85 | |||||
EV-to-EBITDA | -4.85 | |||||
EV-to-FCF | -6.17 | |||||
| Price-to-Net-Current-Asset-Value | 13.4 | |||||
| Price-to-Net-Cash | 13.4 | |||||
Earnings Yield (Greenblatt) % | -20.62 | |||||
FCF Yield % | -16.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lir Life Sciences Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.058 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 56 | ||
| 14-Day ATR (€) | 0.013132 | ||
| 20-Day SMA (€) | 0.236 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.212 - 1.58 | ||
| Shares Outstanding (Mil) | 27.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lir Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lir Life Sciences Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lir Life Sciences Corp Frequently Asked Questions
What is Lir Life Sciences Corp(FRA:N790)'s stock price today?
The current price of FRA:N790 is €0.27. The 52 week high of FRA:N790 is €1.58 and 52 week low is €0.21.
When is next earnings date of Lir Life Sciences Corp(FRA:N790)?
The next earnings date of Lir Life Sciences Corp(FRA:N790) is .
Does Lir Life Sciences Corp(FRA:N790) pay dividends? If so, how much?
Lir Life Sciences Corp(FRA:N790) does not pay dividend.
Press Release
Articles on Lir Life Sciences Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers